Mario Capasso

34PUBLICATIONS
113CO-AUTHORS
Tissue engineeringEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursNeurogeneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 06, 2026
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.

|May 13, 2026
Correction: Position statement from the Italian Society of Human Genetics (SIGU) on the implementation of germline pharmacogenetic testing.

|Apr 02, 2026
Position statement from the Italian Society of Human Genetics (SIGU) on the implementation of germline pharmacogenetic testing.

Matteo Floris, Antonino Moschella, Mario Capasso

|Jan 28, 2026
Targeted Therapy for a Rare PDGFRB-Rearranged Myeloproliferative Neoplasm: A Case Report.

Cosimo Barbato, Vito A Lasorsa, Francesco Grimaldi

|Jun 17, 2025
The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid Metabolism.

Teresa Maiorino, Marianna Avitabile, Vincenzo Aievola

|Jan 22, 2025
Regulatory non-coding somatic mutations as drivers of neuroblastoma.

Annalaura Montella, Matilde Tirelli, Vito Alessandro Lasorsa

Pageof 6

Frequent Collaborators

7 joint publications

Vito Alessandro Lasorsa

6 joint publications

Roberta Russo

6 joint publications

Achille Iolascon

5 joint publications

Immacolata Andolfo